Human cloning, regenerative therapy need regulation: Nobel laureates
05/08/2018 08:51 AM
Taipei, May 8 (CNA) While stem cell research holds potential for understanding and treating diseases, regulation of its application is of equal importance in view of the unscrupulous marketing tactics touting regenerative therapy and the progress being made toward human cloning, Nobel Prize-winning scientists said in Taipei recently.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 0.73%
03/29/2024 02:03 PM - Society
Media personality Lucifer Chu gets jail time for indecent assault
03/29/2024 01:34 PM - Business
Lenovo lays off 92 employees in Taiwan: Labor ministry
03/29/2024 12:30 PM - Sports
Breaking the wall: Pro Go player Hsu Ching-en eyes top spot in Taiwan
03/29/2024 12:01 PM - Society
Taiwan headline news
03/29/2024 11:03 AM